Clinical Trial Update: Metformin Hydrochloride vs. Placebo in Overweight or Obese Patients at Elevated Risk for Breast Cancer [EARLY_Phase 1]

View source ↗

Summary

An early-phase 1 study comparing metformin hydrochloride to placebo in overweight or obese individuals at elevated risk for breast cancer has completed.

Upgrade for the full analysis, importance score, and drug timeline.

Diseases / indications

• Breast Cancer
• Obesity

Drugs mentioned

• METFORMIN HYDROCHLORIDE (Metformin hydrochloride)

Snippet

Sponsor: Anna Maria Storniolo | Conditions: Breast Cancer, Obesity | EARLY_Phase 1 | Status: COMPLETED